Skip to main content
03/04/2007 - 22:00

Atwell resigns as C3 to sell CellSpray, close US offices

03/04/2007 - 22:00

Bookmark

Save articles for future reference.

PERTH-BASED burns treatment developer Clinical Cell Culture Ltd, or C3, announced it will close its American offices and sell its CellSpray technology after completing a strategic review of its options.

X

To read our articles you will need to either login or subscribe.